Validating Two New Rating Scales for Non-motor Symptoms in Parkinson's Disease
Checks two new rating scales that measure non-motor symptoms in people with Parkinson's disease.
Plain-language title generated from the registry record
Registry title: International Validation of Two Non-motor Scales in PD (NFS and SPARK)
Key facts
- Where
- Burgos and Madrid, SpainSee the 2 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with Parkinson's disease to test two new scales that measure non-motor symptoms and shame in Parkinson's disease.
- Age
- Older than 30 and younger than 75 years.
- Sex
- All sexes can join.
- Disease stage
- Parkinson's disease diagnosed according to the MDS criteria.
Main reasons for not taking part
- Parkinson's disease dementia (MoCA score below 24)
- Not fluent in the language in which the scales are used
- No written informed consent
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 75 years old?
Source: NCT04366804, who can take part
Where in Spain
- Hospital Universitario BurgosBurgos, SpainNo longer taking part
- Ruber International HospitalMadrid, SpainNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Insel Gruppe AG, University Hospital Bern
- Trial code
- NCT04366804
- Record updated
- 13 April 2025
- Original description
The goal of this project is to develop the international validation of two new rating scales, the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in PARKinson's disease (SPARK) Scale, in order to improve the understanding of the extent and severity of non-motor symptoms in Parkinson's disease (PD).Read full original descriptionShow less
International Validation of Two Non-motor Scales in Parkinson's Disease: the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in Parkinson's Disease (SPARK) Scale
The goal of this project is to develop the international validation of two new rating scales, the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in PARKinson's disease (SPARK) Scale, in order to improve the understanding of the extent and severity of non-motor symptoms in Parkinson's disease (PD).
Inclusion: Written informed consent; PD, according to the MDS criteria; Age of participants > 30 and < 75 years; Being fluent in the language in which the scales are applied.
Exclusion: Presence of PD dementia (defined as MoCA score < 24).